Poxel S.A. (EPA:POXEL)
 0.3325
 +0.0225 (7.26%)
  Nov 3, 2025, 5:35 PM CET
Poxel Employees
Poxel had 6 employees as of December 31, 2023. The number of employees decreased by 31 or -83.78% compared to the previous year.
Employees 
 6
Change (1Y) 
 -31
Growth (1Y) 
 -83.78%
Revenue / Employee 
 €1,106,000
Profits / Employee 
 €3,050,833
Market Cap 
17.87M
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2023 | 6 | -31 | -83.78% | 
| Dec 31, 2022 | 37 | -18 | -32.73% | 
| Dec 31, 2021 | 55 | 5 | 10.00% | 
| Dec 31, 2020 | 50 | 3 | 6.38% | 
| Dec 31, 2019 | 47 | 14 | 42.42% | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Related Stocks
| Company Name | Employees | 
|---|---|
| EssilorLuxottica Société anonyme | 153,498 | 
| emeis Société anonyme | 83,494 | 
| Sanofi | 82,878 | 
| Eurofins Scientific SE | 62,696 | 
| Clariane SE | 61,798 | 
| bioMérieux | 14,754 | 
| Sartorius Stedim Biotech | 9,901 | 
| Virbac | 6,365 | 
Poxel News
- 3 days ago - Appointment of Yves Decadt as Member of Poxel's Board of Directors - Business Wire
 - 18 days ago - Poxel Reports Financial Results for Full Year 2024 and Provides Operational and Financial Update - Business Wire
 - 3 months ago - Following the Filing for the Opening of Reorganization Proceedings, Poxel Announces Changes to Its Corporate Governance - Business Wire
 - 3 months ago - Poxel Provides Update on Negotiations with Creditors and Announces Filing of Reorganization Proceedings, Upcoming Change of Corporate Governance and Suspension of Trading - Business Wire
 - 4 months ago - Poxel Announces Postponement of its Annual General Meeting and Provides a Corporate Update - Business Wire
 - 4 months ago - Poxel SA: New Scientific Presentations by Key Opinion Leaders to Further Highlight the Therapeutic Potential of Imeglimin at ADA 2025, the Leading Diabetes Conference - Business Wire
 - 5 months ago - New Clinical and Scientific Data on TWYMEEG® to be Presented at the 68th Annual Meeting of the Japan Diabetes Society - Benzinga
 - 5 months ago - Poxel Announces Positive Preclinical Data for PXL065 in Hypertrophic Cardiomyopathy To Be Presented at the ESC Congress 2025 - Business Wire